FY2024 Earnings Forecast for ACHC Issued By Leerink Partnrs

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Stock analysts at Leerink Partnrs cut their FY2024 earnings per share estimates for Acadia Healthcare in a research report issued to clients and investors on Friday, November 1st. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $3.42 for the year, down from their previous estimate of $3.50. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.76 EPS, Q2 2025 earnings at $0.97 EPS and Q3 2025 earnings at $0.95 EPS.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the company earned $0.91 EPS.

A number of other brokerages have also weighed in on ACHC. KeyCorp started coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating for the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday, September 20th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft raised their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, Barclays lowered their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $86.67.

Acadia Healthcare Trading Down 1.6 %

Shares of NASDAQ ACHC opened at $42.02 on Monday. The business’s 50 day moving average price is $65.72 and its 200-day moving average price is $67.77. Acadia Healthcare has a fifty-two week low of $41.75 and a fifty-two week high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.07. The company has a market cap of $3.90 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 1.28 and a beta of 1.33.

Institutional Trading of Acadia Healthcare

A number of institutional investors have recently made changes to their positions in ACHC. Commonwealth Equity Services LLC increased its position in Acadia Healthcare by 10.7% during the first quarter. Commonwealth Equity Services LLC now owns 7,338 shares of the company’s stock worth $581,000 after purchasing an additional 708 shares during the last quarter. BNP Paribas Financial Markets grew its position in shares of Acadia Healthcare by 77.1% in the 1st quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company’s stock valued at $1,700,000 after buying an additional 9,342 shares during the last quarter. Texas Permanent School Fund Corp boosted its stake in Acadia Healthcare by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 80,706 shares of the company’s stock valued at $6,394,000 after acquiring an additional 1,045 shares in the last quarter. Sei Investments Co. grew its stake in Acadia Healthcare by 1.2% during the 1st quarter. Sei Investments Co. now owns 290,050 shares of the company’s stock worth $22,977,000 after buying an additional 3,523 shares during the last quarter. Finally, Headlands Technologies LLC grew its position in shares of Acadia Healthcare by 145.3% during the first quarter. Headlands Technologies LLC now owns 4,484 shares of the company’s stock worth $355,000 after acquiring an additional 2,656 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.